Post‑Transplant, JC Virus DNA, RT PCR, Plasma
Use
JC Polyoma Virus is the cause of Progressive Multifocal Leukoencephalopathy (PML), a severe demyelinating disease of the central nervous system. PML is a particular concern for individuals infected with the human immunodeficiency virus. Quantification of JC virus DNA is based upon the real‑time PCR amplification and detection of JCV genomic DNA. Reportable range is 50 to 50,000,000 IU/mL (1.70 to 7.70 Log IU/mL).
Special Instructions
Not provided.
Limitations
Laboratory test results should always be considered in the context of clinical observations. This test was developed, and its performance characteristics determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes.
Methodology
PCR-based (RT-PCR)
Biomarkers
JC Virus DNA
Other
Result Turnaround Time
1 day
Related Documents
For more information, please review the documents below
Specimen
Plasma
Volume
1 mL
Minimum Volume
0.5 mL
Container
EDTA (lavender‑top) tube
Collection Instructions
Plasma collected in an EDTA (lavender‑top) tube. For Shipper collection please see detailed instructions in Test Resources.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 7 days |
| Frozen | 30 days |
Other tests from different labs that may be relevant